DarioHealth Corp. (NASDAQ: DRIO) Stock Competitors & Peer Comparison
See DRIO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for DRIO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DRIO | $7.24 | +3.72% | 52.9M | -1.24 | -$5.86 | N/A |
| ALC | $70.50 | -2.19% | 34.4B | 22.17 | $3.18 | +0.51% |
| STE | $224.59 | -0.99% | 21.9B | 21.56 | $10.42 | +1.15% |
| QDEL | $13.97 | +0.29% | 952.6M | 10.43 | $1.34 | N/A |
| MLAB | $127.78 | -0.58% | 715M | 12.89 | $9.91 | +0.50% |
| BWAY | $14.15 | -2.48% | 555M | 35.95 | $0.39 | N/A |
| SI | $20.32 | -0.34% | 421.4M | -10.61 | -$1.91 | N/A |
| MASS | $10.05 | +0.10% | 412.3M | -16.75 | -$0.60 | N/A |
| MOBI | $11.63 | +0.00% | 386.7M | -0.62 | -$18.78 | N/A |
| ANIK | $20.81 | -0.90% | 278.5M | 42.47 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
DRIO vs ALC Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, ALC has a market cap of 34.4B. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while ALC trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas ALC's P/E ratio is 22.17. In terms of profitability, DRIO's ROE is +1.04%, compared to ALC's ROE of +0.03%. Regarding short-term risk, DRIO is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check ALC's competition here
STERIS plc (NYSE: STE)
DRIO vs STE Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, STE has a market cap of 21.9B. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while STE trades at $224.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas STE's P/E ratio is 21.56. In terms of profitability, DRIO's ROE is +1.04%, compared to STE's ROE of +0.11%. Regarding short-term risk, DRIO is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
DRIO vs QDEL Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, QDEL has a market cap of 952.6M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while QDEL trades at $13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas QDEL's P/E ratio is 10.43. In terms of profitability, DRIO's ROE is +1.04%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, DRIO is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
DRIO vs MLAB Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, MLAB has a market cap of 715M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while MLAB trades at $127.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas MLAB's P/E ratio is 12.89. In terms of profitability, DRIO's ROE is +1.04%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, DRIO is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
DRIO vs BWAY Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, BWAY has a market cap of 555M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while BWAY trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas BWAY's P/E ratio is 35.95. In terms of profitability, DRIO's ROE is +1.04%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, DRIO is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check BWAY's competition here
Shoulder Innovations, Inc. (NYSE: SI)
DRIO vs SI Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, SI has a market cap of 421.4M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while SI trades at $20.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas SI's P/E ratio is -10.61. In terms of profitability, DRIO's ROE is +1.04%, compared to SI's ROE of -0.26%. Regarding short-term risk, DRIO is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check SI's competition here
908 Devices Inc. (NASDAQ: MASS)
DRIO vs MASS Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, MASS has a market cap of 412.3M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while MASS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas MASS's P/E ratio is -16.75. In terms of profitability, DRIO's ROE is +1.04%, compared to MASS's ROE of -0.25%. Regarding short-term risk, DRIO is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
DRIO vs MOBI Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, MOBI has a market cap of 386.7M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while MOBI trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas MOBI's P/E ratio is -0.62. In terms of profitability, DRIO's ROE is +1.04%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, DRIO is more volatile compared to MOBI. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
DRIO vs ANIK Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, ANIK has a market cap of 278.5M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while ANIK trades at $20.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas ANIK's P/E ratio is 42.47. In terms of profitability, DRIO's ROE is +1.04%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, DRIO is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
DRIO vs LAB Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, LAB has a market cap of 268.3M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while LAB trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas LAB's P/E ratio is -9.79. In terms of profitability, DRIO's ROE is +1.04%, compared to LAB's ROE of -0.18%. Regarding short-term risk, DRIO is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check LAB's competition here
Trinity Biotech plc (NASDAQ: TRIB)
DRIO vs TRIB Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, TRIB has a market cap of 190.6M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while TRIB trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas TRIB's P/E ratio is -0.16. In terms of profitability, DRIO's ROE is +1.04%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, DRIO is more volatile compared to TRIB. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check TRIB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
DRIO vs EDAP Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas EDAP's P/E ratio is -5.80. In terms of profitability, DRIO's ROE is +1.04%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, DRIO is more volatile compared to EDAP. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
DRIO vs NYXH Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while NYXH trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas NYXH's P/E ratio is -0.64. In terms of profitability, DRIO's ROE is +1.04%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, DRIO is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for DRIO.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
DRIO vs APYX Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, APYX has a market cap of 128.4M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while APYX trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas APYX's P/E ratio is -15.25. In terms of profitability, DRIO's ROE is +1.04%, compared to APYX's ROE of -0.79%. Regarding short-term risk, DRIO is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
DRIO vs SKIN Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, SKIN has a market cap of 88.8M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while SKIN trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas SKIN's P/E ratio is -3.11. In terms of profitability, DRIO's ROE is +1.04%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, DRIO is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
DRIO vs MDAI Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, MDAI has a market cap of 50M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while MDAI trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas MDAI's P/E ratio is -3.49. In terms of profitability, DRIO's ROE is +1.04%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, DRIO is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check MDAI's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
DRIO vs BEAT Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, BEAT has a market cap of 23.7M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while BEAT trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas BEAT's P/E ratio is -0.84. In terms of profitability, DRIO's ROE is +1.04%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, DRIO is more volatile compared to BEAT. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
DRIO vs BEATW Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, BEATW has a market cap of 8.4M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas BEATW's P/E ratio is -0.02. In terms of profitability, DRIO's ROE is +1.04%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, DRIO is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for DRIO.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
DRIO vs WOK Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while WOK trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas WOK's P/E ratio is N/A. In terms of profitability, DRIO's ROE is +1.04%, compared to WOK's ROE of -0.19%. Regarding short-term risk, DRIO is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
DRIO vs QTEXW Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, DRIO's ROE is +1.04%, compared to QTEXW's ROE of N/A. Regarding short-term risk, DRIO is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for DRIO.Check QTEXW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
DRIO vs FEED Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, FEED has a market cap of 3.1M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while FEED trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas FEED's P/E ratio is -0.03. In terms of profitability, DRIO's ROE is +1.04%, compared to FEED's ROE of -0.60%. Regarding short-term risk, DRIO is more volatile compared to FEED. This indicates higher risk in terms of short-term price fluctuations for DRIO.Check FEED's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
DRIO vs ITOC Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, ITOC has a market cap of 2.8M. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while ITOC trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas ITOC's P/E ratio is -0.95. In terms of profitability, DRIO's ROE is +1.04%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, DRIO is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for DRIO.Check ITOC's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
DRIO vs TIVC Comparison September 2026
DarioHealth Corp. (NASDAQ: DRIO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRIO stands at 52.9M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, DRIO is priced at $7.24 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRIO currently has a P/E ratio of -1.24, whereas TIVC's P/E ratio is -0.04. In terms of profitability, DRIO's ROE is +1.04%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, DRIO is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for DRIO.Check TIVC's competition here